Glecaprevir (CAS 1365970-03-1)

« Back to Anti-Hepatitis API

Glecaprevir

CAS No. 1365970-03-1
格卡瑞韦
Glecaprevir structure
Chemical structure
CAS No.1365970-03-1
Synonyms(1R,2R)-N-[[[(1R,2R)-2-[[4,4-Difluoro-4-(3-hydroxy-2-quinoxalinyl)-2-buten-1-yl]oxy]cyclopentyl]oxy]carbonyl]-3-methyl-L-valyl-(4R)-4-hydroxy-L-prolyl-1-amino-2-(difluoromethyl)-N-[(1-methylcyclopropyl)sulfonyl]cyclopropanecarboxamide cyclic (1→2)-ether; A 1282576.0; ABT 493
CategoryAnti-Hepatitis API / Anti-Hepatitis
Assay / Purity99%
Molecular FormulaC38H46F4N6O9S
Molecular Weight838.9
Melting Point—
Boiling Point—
Density—
Flash Point—
AppearanceOff-white to white solid powder

Application and positioning

Glecaprevir is an NS3/4A protease inhibitor supplied as the free acid. It is used in pangenotypic direct-acting antiviral tablets for chronic hepatitis C, combined with pibrentasvir. Laurand supplies it from audited Chinese production partners for pharmaceutical manufacturing and process development.

Quality and documentation

  • Batch-specific Certificate of Analysis issued by the manufacturing site
  • SDS/MSDS and specification sheet available on request
  • Residual solvents and elemental impurities statements discussed per project
  • For pharmaceutical manufacturing and R&D use only — not for direct administration

Packaging and handling

  • Packed in double polyethylene-lined fibre drums; pack size confirmed at quotation
  • Small quantities in sealed aluminium foil bags
  • Palletised for air and sea freight; store dry, ventilated and protected from light

Related products

Specifications shown are indicative. The final specification and documentation package are confirmed with the quotation.

Interested in this product?

Contact us for price, COA, MSDS and lead time — custom synthesis available.

Request a Quote

Reference: CAS 1365970-03-1 · PubChem CID 66828839